BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 24818480)

  • 21. [Engineering MEP pathway in Escherichia coli for amorphadiene production and optimizing the bioprocess through glucose feeding control].
    Wang J; Xiong Z; Zhang S; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2014 Jan; 30(1):64-75. PubMed ID: 24818480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An account of cloned genes of Methyl-erythritol-4-phosphate pathway of isoprenoid biosynthesis in plants.
    Ganjewala D; Kumar S; Luthra R
    Curr Issues Mol Biol; 2009; 11 Suppl 1():i35-45. PubMed ID: 19193963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positioning Bacillus subtilis as terpenoid cell factory.
    Pramastya H; Song Y; Elfahmi EY; Sukrasno S; Quax WJ
    J Appl Microbiol; 2021 Jun; 130(6):1839-1856. PubMed ID: 33098223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Network analysis of the MVA and MEP pathways for isoprenoid synthesis.
    Vranová E; Coman D; Gruissem W
    Annu Rev Plant Biol; 2013; 64():665-700. PubMed ID: 23451776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoprenoid biosynthesis via 1-deoxy-D-xylulose 5-phosphate/2-C-methyl-D-erythritol 4-phosphate (DOXP/MEP) pathway.
    Wanke M; Skorupinska-Tudek K; Swiezewska E
    Acta Biochim Pol; 2001; 48(3):663-72. PubMed ID: 11833775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies of isoprenoids production in engineered bacteria.
    Li Y; Wang G
    J Appl Microbiol; 2016 Oct; 121(4):932-40. PubMed ID: 27428054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-mevalonate isoprenoid biosynthesis: enzymes, genes and inhibitors.
    Lichtenthaler HK
    Biochem Soc Trans; 2000 Dec; 28(6):785-9. PubMed ID: 11171208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breaking new ground in the regulation of the early steps of plant isoprenoid biosynthesis.
    Rodríguez-Concepción M; Boronat A
    Curr Opin Plant Biol; 2015 Jun; 25():17-22. PubMed ID: 25909859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic engineering strategies for sesquiterpene production in microorganism.
    Liu CL; Xue K; Yang Y; Liu X; Li Y; Lee TS; Bai Z; Tan T
    Crit Rev Biotechnol; 2022 Feb; 42(1):73-92. PubMed ID: 34256675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic engineering and synthetic biology for isoprenoid production in Escherichia coli and Saccharomyces cerevisiae.
    Navale GR; Dharne MS; Shinde SS
    Appl Microbiol Biotechnol; 2021 Jan; 105(2):457-475. PubMed ID: 33394155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoprenoid biosynthesis in eukaryotic phototrophs: a spotlight on algae.
    Lohr M; Schwender J; Polle JE
    Plant Sci; 2012 Apr; 185-186():9-22. PubMed ID: 22325862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic engineering of Bacillus subtilis for terpenoid production.
    Guan Z; Xue D; Abdallah II; Dijkshoorn L; Setroikromo R; Lv G; Quax WJ
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9395-406. PubMed ID: 26373726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action.
    Bergman ME; Davis B; Phillips MA
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31683764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives.
    Allamand A; Piechowiak T; Lièvremont D; Rohmer M; Grosdemange-Billiard C
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoprenoid biosynthesis in bacterial pathogens.
    Heuston S; Begley M; Gahan CGM; Hill C
    Microbiology (Reading); 2012 Jun; 158(Pt 6):1389-1401. PubMed ID: 22466083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative metabolic pathways and strategies to high-titre terpenoid production in
    Rinaldi MA; Ferraz CA; Scrutton NS
    Nat Prod Rep; 2022 Jan; 39(1):90-118. PubMed ID: 34231643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic engineering of Escherichia coli for the production of isoprenoids.
    Ward VCA; Chatzivasileiou AO; Stephanopoulos G
    FEMS Microbiol Lett; 2018 May; 365(10):. PubMed ID: 29718190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for enhancing terpenoids accumulation in microalgae.
    Huang PW; Wang LR; Geng SS; Ye C; Sun XM; Huang H
    Appl Microbiol Biotechnol; 2021 Jun; 105(12):4919-4930. PubMed ID: 34125275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research progress in multi-enzyme regulation of genetically engineered bacteria producing lycopene].
    Xu J; Zuo S; Xie C; Jiang L; Li S; Huang H; Xu X
    Sheng Wu Gong Cheng Xue Bao; 2017 Apr; 33(4):552-564. PubMed ID: 28920389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis and engineering of isoprenoid small molecules.
    Withers ST; Keasling JD
    Appl Microbiol Biotechnol; 2007 Jan; 73(5):980-90. PubMed ID: 17115212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.